CIK 0001621227 · Non-accelerated filer<br>Smaller reporting company
Adaptimmune Therapeutics PLC
Sign in to watch- Ticker
- ADAPY
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 44 1235 430000
- Business address
- 60 JUBILEE AVENUE, MILTON PARK, ABINGDON, OXFORDSHIRE, United Kingdom
- Former names
- Adaptimmune Ltd
- 8-K Event Regulation FD disclosure
- 8-K Event Other events
- 8-K Event Other events
- DEF 14A Proxy Proxy Statement
- 8-K Event Executive or director change
- PRE 14A Proxy Proxy Statement (Preliminary)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 10-K Report Annual Report
- 8-K Event Results of operations
- 8-K Event Executive or director change · Other events
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Other events
- 4 Open-market buy 10% owner bought 7,500,000 shares at $0.67 ($5,000,250)
- 4 Open-market buy 10% owner bought 7,500,000 shares at $0.67 ($5,000,250)
- 4 Open-market buy Director bought 7,500,000 shares at $0.67 ($5,000,250)
- 4 Open-market buy 10% owner bought 7,500,000 shares at $0.67 ($5,000,250)
- 4 Open-market buy Director bought 7,500,000 shares at $0.67 ($5,000,250)
Page 20 of 41 · 808 filings